<p>AdaptHealth Corp.（納斯達克代碼：AHCO - 獲取免費報告）在週一的午盤交易中，股價創下 52 周新低。該股最低交易價為 7.40 美元，最後交易價為 7.59 美元，成交量為 824 股。該股此前收盤價為 7.79 美元。</p>
<h2>分析師評級調整</h2>
<ul>
<li>3 只小型股領軍者有望實現顯著增長</li>
</ul>
<p>多家股票分析師對 AHCO 股票發佈了報告。瑞銀集團將 AdaptHealth 的目標價從 12.00 美元下調至 11.00 美元，並在 2 月 13 日的報告中給予該公司 “買入” 評級。加拿大皇家銀行將 AdaptHealth 的目標價從 11.00 美元上調至 14.00 美元，並在 2 月 26 日的報告中給予該股 “跑贏大盤” 評級。Canaccord Genuity Group 將 AdaptHealth 的目標價從 13.00 美元上調至 14.00 美元，並在 2 月 26 日的研究報告中給予該股 “買入” 評級。羅伯特·W·貝爾德將 AdaptHealth 的目標價從 14.00 美元上調至 16.00 美元，並在 2 月 27 日的研究報告中給予該公司 “跑贏大盤” 評級。最後，Truist Financial 將 AdaptHealth 的目標價從 12.00 美元上調至 14.00 美元，並在 2 月 26 日的報告中給予該公司 “買入” 評級。五位研究分析師對該股給予了 “買入” 評級，根據 MarketBeat.com 的數據，AdaptHealth 目前的平均評級為 “買入”，平均目標價為 13.80 美元。</p>
<p><strong>查看我們關於 AdaptHealth 的最新報告</strong></p>
<h2>AdaptHealth 股票表現</h2>
<p>該公司的市值為 10.2 億美元，市盈率為-4.59，PEG 比率為 1.08，貝塔值為 1.44。該公司的 50 日簡單移動平均線為 9.70 美元，200 日簡單移動平均線為 9.96 美元。該公司的流動比率為 1.24，速動比率為 1.00，債務與股本比率為 1.34。</p>
<h2>AdaptHealth 的機構交易</h2>
<p>多家機構投資者和對沖基金最近買入和賣出了該股票的股份。Assetmark Inc.在第四季度新購入了價值約 28,000 美元的 AdaptHealth 股份。Blue Trust Inc.在第四季度將其在 AdaptHealth 的持股比例提高了 24.1%。Blue Trust Inc.目前擁有 5,746 股該公司的股票，價值 55,000 美元，此前在上個季度增持了 1,115 股。GAMMA Investing LLC 在第一季度將其在 AdaptHealth 的持股比例提高了 175.2%。GAMMA Investing LLC 目前擁有 7,473 股該公司的股票，價值 81,000 美元，此前在此期間增持了 4,758 股。Empirical Financial Services LLC（以 Empirical Wealth Management 名義運營）在第四季度將其在 AdaptHealth 的持股比例提高了 15.4%。Empirical Financial Services LLC 目前擁有 12,663 股該公司的股票，價值 121,000 美元，此前在上個季度增持了 1,690 股。最後，Guggenheim Capital LLC 在第四季度將其在 AdaptHealth 的持股比例提高了 10.1%。Guggenheim Capital LLC 目前擁有 16,613 股該公司的股票，價值 158,000 美元，此前在上個季度增持了 1,525 股。82.67% 的股票目前由機構投資者持有。</p>
<h2>AdaptHealth 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>AdaptHealth Corp.及其子公司在美國銷售家庭醫療設備（HME）、醫療用品以及家庭和相關服務。該公司提供睡眠治療設備、用品及相關服務，如為患有阻塞性睡眠呼吸暫停的個人提供 CPAP 和 bi-PAP 服務；醫療設備和用品，包括用於糖尿病治療的連續血糖監測儀和胰島素泵；向從急性護理和其他設施出院的患者提供 HME；在家中提供氧氣和相關慢性治療服務；以及代表慢性病患者提供傷口護理、泌尿、失禁、造口和營養供應需求的其他 HME 設備和用品。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 AdaptHealth</li>
<li>電話會議與個人投資者</li>
<li>這個波動的市場適合對這些股票進行小額投資</li>
<li>Roth IRA 計算器：計算您的潛在回報</li>
<li>黃金創下歷史新高，但這種安靜的金屬也在上漲</li>
<li>為什麼除息日對投資者來説意義重大？</li>
<li>D-Wave Quantum 因芯片新聞下滑：是否是買入機會？</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 AdaptHealth 嗎？</h2>
<p>在考慮投資 AdaptHealth 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 AdaptHealth 並不在名單上。</p>
<p>雖然 AdaptHealth 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得投資。</p>
<p>查看這五隻股票</p>

AHCO

<p>AdaptHealth Corp.（納斯達克代碼：AHCO）創下了 52 周新低，報 7.40 美元，收盤價為 7.59 美元，交易量為 824 股。分析師的看法不一，瑞銀將其目標價從 12.00 美元下調至 11.00 美元，而加拿大皇家銀行則將目標價從 11.00 美元上調至 14.00 美元。該股票的平均評級為 “買入”，目標價為 13.80 美元。機構投資者持有該股票的 82.67%，公司專注於家庭醫療設備及相關服務</p>

<p>AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $7.40 and last traded at $7.59, with a volume of 824 shares traded. The stock had previously closed at $7.79.</p>
<div class="lb-trans"><p>AdaptHealth Corp.（納斯達克代碼：AHCO - 獲取免費報告）在週一的午盤交易中，股價創下 52 周新低。該股最低交易價為 7.40 美元，最後交易價為 7.59 美元，成交量為 824 股。該股此前收盤價為 7.79 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><ul>
<li>3 Small-Cap Leaders Poised for Significant Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只小型股領軍者有望實現顯著增長</li>
</ul>
</div><p>A number of equities analysts have issued reports on AHCO shares. UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a &#34;buy&#34; rating for the company in a report on Thursday, February 13th. Royal Bank of Canada upped their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, February 26th. Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, February 26th. Robert W. Baird lifted their price objective on AdaptHealth from $14.00 to $16.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, February 27th. Finally, Truist Financial raised their price target on AdaptHealth from $12.00 to $14.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth presently has an average rating of &#34;Buy&#34; and an average target price of $13.80.</p>
<div class="lb-trans"><p>多家股票分析師對 AHCO 股票發佈了報告。瑞銀集團將 AdaptHealth 的目標價從 12.00 美元下調至 11.00 美元，並在 2 月 13 日的報告中給予該公司 “買入” 評級。加拿大皇家銀行將 AdaptHealth 的目標價從 11.00 美元上調至 14.00 美元，並在 2 月 26 日的報告中給予該股 “跑贏大盤” 評級。Canaccord Genuity Group 將 AdaptHealth 的目標價從 13.00 美元上調至 14.00 美元，並在 2 月 26 日的研究報告中給予該股 “買入” 評級。羅伯特·W·貝爾德將 AdaptHealth 的目標價從 14.00 美元上調至 16.00 美元，並在 2 月 27 日的研究報告中給予該公司 “跑贏大盤” 評級。最後，Truist Financial 將 AdaptHealth 的目標價從 12.00 美元上調至 14.00 美元，並在 2 月 26 日的報告中給予該公司 “買入” 評級。五位研究分析師對該股給予了 “買入” 評級，根據 MarketBeat.com 的數據，AdaptHealth 目前的平均評級為 “買入”，平均目標價為 13.80 美元。</p>
</div><p><strong>View Our Latest Report on AdaptHealth</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 AdaptHealth 的最新報告</strong></p>
</div><h2>AdaptHealth Stock Performance</h2>
<div class="lb-trans"><h2>AdaptHealth 股票表現</h2>
</div><p>The company has a market cap of $1.02 billion, a P/E ratio of -4.59, a PEG ratio of 1.08 and a beta of 1.44. The business's 50 day simple moving average is $9.70 and its 200 day simple moving average is $9.96. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.</p>
<div class="lb-trans"><p>該公司的市值為 10.2 億美元，市盈率為-4.59，PEG 比率為 1.08，貝塔值為 1.44。該公司的 50 日簡單移動平均線為 9.70 美元，200 日簡單移動平均線為 9.96 美元。該公司的流動比率為 1.24，速動比率為 1.00，債務與股本比率為 1.34。</p>
</div><h2>Institutional Trading of AdaptHealth</h2>
<div class="lb-trans"><h2>AdaptHealth 的機構交易</h2>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Assetmark Inc. bought a new position in shares of AdaptHealth during the 4th quarter valued at approximately $28,000. Blue Trust Inc. raised its stake in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after buying an additional 4,758 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after acquiring an additional 1,690 shares in the last quarter. Finally, Guggenheim Capital LLC boosted its stake in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>多家機構投資者和對沖基金最近買入和賣出了該股票的股份。Assetmark Inc.在第四季度新購入了價值約 28,000 美元的 AdaptHealth 股份。Blue Trust Inc.在第四季度將其在 AdaptHealth 的持股比例提高了 24.1%。Blue Trust Inc.目前擁有 5,746 股該公司的股票，價值 55,000 美元，此前在上個季度增持了 1,115 股。GAMMA Investing LLC 在第一季度將其在 AdaptHealth 的持股比例提高了 175.2%。GAMMA Investing LLC 目前擁有 7,473 股該公司的股票，價值 81,000 美元，此前在此期間增持了 4,758 股。Empirical Financial Services LLC（以 Empirical Wealth Management 名義運營）在第四季度將其在 AdaptHealth 的持股比例提高了 15.4%。Empirical Financial Services LLC 目前擁有 12,663 股該公司的股票，價值 121,000 美元，此前在上個季度增持了 1,690 股。最後，Guggenheim Capital LLC 在第四季度將其在 AdaptHealth 的持股比例提高了 10.1%。Guggenheim Capital LLC 目前擁有 16,613 股該公司的股票，價值 158,000 美元，此前在上個季度增持了 1,525 股。82.67% 的股票目前由機構投資者持有。</p>
</div><h2>AdaptHealth Company Profile</h2>
<div class="lb-trans"><h2>AdaptHealth 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.</p>
<div class="lb-trans"><p>AdaptHealth Corp.及其子公司在美國銷售家庭醫療設備（HME）、醫療用品以及家庭和相關服務。該公司提供睡眠治療設備、用品及相關服務，如為患有阻塞性睡眠呼吸暫停的個人提供 CPAP 和 bi-PAP 服務；醫療設備和用品，包括用於糖尿病治療的連續血糖監測儀和胰島素泵；向從急性護理和其他設施出院的患者提供 HME；在家中提供氧氣和相關慢性治療服務；以及代表慢性病患者提供傷口護理、泌尿、失禁、造口和營養供應需求的其他 HME 設備和用品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than AdaptHealth</li>
<li>Conference Calls and Individual Investors</li>
<li>This Volatile Market Is Made For Nickel-and-Diming These Names</li>
<li>Roth IRA Calculator: Calculate Your Potential Returns</li>
<li>Gold Is Making All-Time Highs, But So Is This Quiet Metal</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>D-Wave Quantum Slides on Chip News: Opportunity to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 AdaptHealth</li>
<li>電話會議與個人投資者</li>
<li>這個波動的市場適合對這些股票進行小額投資</li>
<li>Roth IRA 計算器：計算您的潛在回報</li>
<li>黃金創下歷史新高，但這種安靜的金屬也在上漲</li>
<li>為什麼除息日對投資者來説意義重大？</li>
<li>D-Wave Quantum 因芯片新聞下滑：是否是買入機會？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in AdaptHealth Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 AdaptHealth 嗎？</h2>
</div><p>Before you consider AdaptHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 AdaptHealth 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 AdaptHealth 並不在名單上。</p>
</div><p>While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 AdaptHealth 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得投資。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

AdaptHealth（納斯達克股票代碼：AHCO）創下 12 個月新低 - 以下是原因